PURE | tickerfilter.com

Fundamental analysis

32%

Profitability 35%

Dept financing 43%

Liquidity 16%

Performance 30%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

5.50%

1 Month

43.59%

3 Months

121.28%

6 Months

13.25%

1 Year

-4.11%

2 Year

32.77%

Key data

Stock price

$0.09

P/E Ratio

N/A

DAY RANGE

$0.09 - $0.10

EPS

-$0.01

52 WEEK RANGE

$0.04 - $0.21

52 WEEK CHANGE

-$4.11

MARKET CAP

0.000

YIELD

N/A

SHARES OUTSTANDING

111.886 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

06-13-2025

BETA

0.00

PUBLIC FLOAT

N/A

AVERAGE 10 VOLUME

$44,920

AVERAGE 30 VOLUME

$44,505

Company detail

CEO:
Region: US
Website: purebio.com
Employees: 10
IPO year: 2013

Issue type:
Market: OTCM
Industry: Chemicals/Misc. Chemical Products
Sector: Manufacturing

PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds.

PURE - PURE BIOSCIENCE, INC.